Drug Type Small molecule drug |
Synonyms HL 001 - Ube Industries, HL-001 - Ube Industries |
Target |
Action antagonists |
Mechanism LPAR1 antagonists(Lysophosphatidic acid receptor Edg-2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Preclinical | - | 30 Mar 2022 | |
Idiopathic Pulmonary Fibrosis | Preclinical | Japan | 30 Mar 2022 |